MIRA MIRA Pharmaceuticals, Inc. - Common Stock

NAS · US · Healthcare · Drug Manufacturers - General · mirapharmaceuticals.com

0.7301USD+0.98%Mkt Cap: 30.68M $P/E: —3d ago

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.…

Industry Peers

Drug Manufacturers - General

Screen all

LLY

Eli Lilly and Company Common Stock

$1.02TUSDP/E 38.4

JNJ

Johnson & Johnson Common Stock

$617.01BUSDP/E 29.7

ABBV

AbbVie Inc. Common Stock

$464.43BUSDP/E 74.2

MRK

Merck & Company, Inc. Common Stock (new)

Novartis AG Common Stock

AstraZeneca PLC Ordinary Shares

Amgen Inc. - Common Stock

Gilead Sciences, Inc. - Common Stock

$179.47BUSD

NVO

Novo Nordisk A/S Common Stock

$164.79BUSDP/E 9.4

PFE

Pfizer, Inc. Common Stock

$158.45BUSDP/E 36.6

BMY

Bristol-Myers Squibb Company Common Stock

$124.91BUSDP/E 13.5

SNY

Sanofi - American Depositary Shares

$95.65BUSDP/E 21.8

GSK

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Key Statistics

Company

Market Cap30.68M USD

Enterprise Value22.57M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-10.44M USD

Revenue/Share—

Last Price0.7301 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees—

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - General

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.78

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B3.76

EPS (TTM)-1.14

EPS (Forward)-0.41

52W Range

0.60007% of range2.450

52W High2.450 USD

52W Low0.6000 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-100.49%

ROA-94.13%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-4.66M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-3.28%

Net Debt-8.11M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio200.08

Quick Ratio198.75

Book Value/Sh0.19 USD

Cash/Share0.19 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)3.500 USD

Upside (mean)+379.4%

Target Range3.500 USD – 3.500 USD

# Analysts1

Ownership

Shares Out.42.02M

Float35.03M

Insiders30.58%

Institutions5.42%

Short Interest

Short Ratio0.3d

Short % Float1.54%

Short % Out.1.07%

Shares Short447.83K

Short (prev mo.)211.08K

Technical

SMA 500.7841 (-6.9%)

SMA 2001.051 (-30.5%)

Beta1.53

S&P 52W Chg14.58%

Avg Vol (30d)1.12M

Avg Vol (10d)180.78K

Technical Indicators

RSI (14)41.6

MACD0.0006

MACD Signal0.0090

MACD Hist.-0.0085

BB Upper0.9397 USD

BB Middle0.8113 USD

BB Lower0.6829 USD

BB Width31.65%

ATR (14)0.0771 USD

Vol Ratio (20d)0.10x